Physician profile
Evan Harmon
NPI 1114422011
$3,025.68
in general payments reported to CMS, 2019-2025
9 companies · $1,683 in 2025
The $1,683 reported for 2025 was more than what 92% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $306 · 2024: $1,036 · 2025: $1,683.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,843 · Education: $183.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,842.93 |
| Education | $182.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $949.71 | 2024-2025 | Portico, Diamondback Coronary, Navitor |
| Edwards Lifesciences Corporation | $771.71 | 2024-2025 | Sapien 3 Ultra Resilia, Pascal, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Medtronic, INC. | $729.13 | 2024-2025 | Corevalve Evolut R, Onyx Frontier, Resolute Onyx |
| Cardiovascular Systems INC. | $276.12 | 2023 | Diamondback Coronary |
| Boston Scientific Corporation | $228.64 | 2023-2025 | Accolade Sr, Opticross, Avvigo Guidance System |
| Philips North America LLC | $32.00 | 2025 | Labosys |
| Abiomed | $22.59 | 2025 | |
| Terumo Medical Corporation | $15.78 | 2025 | Angio-Seal, Azur Cx Detachable |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Evan Harmon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.